100 related articles for article (PubMed ID: 24041698)
1. Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells.
Fox SA; Richards AK; Kusumah I; Perumal V; Bolitho EM; Mutsaers SE; Dharmarajan AM
Biochem Biophys Res Commun; 2013 Oct; 440(1):82-7. PubMed ID: 24041698
[TBL] [Abstract][Full Text] [Related]
2. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.
Uematsu K; Kanazawa S; You L; He B; Xu Z; Li K; Peterlin BM; McCormick F; Jablons DM
Cancer Res; 2003 Aug; 63(15):4547-51. PubMed ID: 12907630
[TBL] [Abstract][Full Text] [Related]
3. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
4. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
[TBL] [Abstract][Full Text] [Related]
5. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
6. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
7. A₃ receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway.
Varani K; Maniero S; Vincenzi F; Targa M; Stefanelli A; Maniscalco P; Martini F; Tognon M; Borea PA
Am J Respir Crit Care Med; 2011 Feb; 183(4):522-30. PubMed ID: 20870754
[TBL] [Abstract][Full Text] [Related]
8. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
Carmon KS; Loose DS
Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
[TBL] [Abstract][Full Text] [Related]
9. Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.
Vehviläinen P; Koli K; Myllärniemi M; Lindholm P; Soini Y; Salmenkivi K; Kinnula VL; Keski-Oja J
Hum Pathol; 2011 Feb; 42(2):269-78. PubMed ID: 21106222
[TBL] [Abstract][Full Text] [Related]
10. Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
Batra S; Shi Y; Kuchenbecker KM; He B; Reguart N; Mikami I; You L; Xu Z; Lin YC; Clément G; Jablons DM
Biochem Biophys Res Commun; 2006 Apr; 342(4):1228-32. PubMed ID: 16516163
[TBL] [Abstract][Full Text] [Related]
11. Altered protease-activated receptor-1 expression and signaling in a malignant pleural mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene.
Fazzini A; D'Antongiovanni V; Giusti L; Da Valle Y; Ciregia F; Piano I; Caputo A; D'Ursi AM; Gargini C; Lucacchini A; Mazzoni MR
PLoS One; 2014; 9(11):e111550. PubMed ID: 25364818
[TBL] [Abstract][Full Text] [Related]
12. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
13. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells.
Mohr S; Bottin MC; Lannes B; Neuville A; Bellocq JP; Keith G; Rihn BH
Biochimie; 2004 Jan; 86(1):13-9. PubMed ID: 14987796
[TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
Song S; Christova T; Perusini S; Alizadeh S; Bao RY; Miller BW; Hurren R; Jitkova Y; Gronda M; Isaac M; Joseph B; Subramaniam R; Aman A; Chau A; Hogge DE; Weir SJ; Kasper J; Schimmer AD; Al-awar R; Wrana JL; Attisano L
Cancer Res; 2011 Dec; 71(24):7628-39. PubMed ID: 22009536
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
16. Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines.
Nygren MK; Døsen G; Hystad ME; Stubberud H; Funderud S; Rian E
Br J Haematol; 2007 Feb; 136(3):400-13. PubMed ID: 17156404
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway.
Goudarzi H; Iizasa H; Furuhashi M; Nakazawa S; Nakane R; Liang S; Hida Y; Yanagihara K; Kubo T; Nakagawa K; Kobayashi M; Irimura T; Hamada J
Cancer Lett; 2013 Oct; 339(1):82-92. PubMed ID: 23879962
[TBL] [Abstract][Full Text] [Related]
18. The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.
Perumal V; Dharmarajan AM; Fox SA
Int J Oncol; 2017 Jul; 51(1):362-368. PubMed ID: 28534940
[TBL] [Abstract][Full Text] [Related]
19. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
20. Cadherins, catenins and APC in pleural malignant mesothelioma.
Abutaily AS; Collins JE; Roche WR
J Pathol; 2003 Nov; 201(3):355-62. PubMed ID: 14595746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
